Oxaliplatin, 5-fluorouracil, and leuvocorin and (FOLFOX-4) combination chemotherapy as salvage treatment in pretreated patients with advanced gastric cancer (AGC)

被引：1
|
作者：
Kim, Y. [1 ]
Park, S. [1 ]
Park, J. [1 ]
Cho, E. [1 ]
Shin, D. [1 ]
Lee, J. [1 ]
机构：
[1] Gachon Univ, Gil Med Ctr, Inchon, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.4577
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4577
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients
    Coriat, Romain
    Mir, Olivier
    Cessot, Anatole
    Brezault, Catherine
    Ropert, Stanislas
    Durand, Jean-Philippe
    Cacheux, Wulfran
    Chaussade, Stanislas
    Goldwasser, Francois
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 376 - 381
  • [22] Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer
    I Chau
    A Webb
    D Cunningham
    M Hill
    J S Waters
    A Norman
    A Massey
    British Journal of Cancer, 2001, 85 : 1258 - 1264
  • [23] Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer
    Chau, I
    Webb, A
    Cunningham, D
    Hill, M
    Waters, JS
    Norman, A
    Massey, A
    BRITISH JOURNAL OF CANCER, 2001, 85 (09) : 1258 - 1264
  • [24] Paclitaxel, oxaliplatin, 5-fluorouracil and leucovorin combination chemotherapy in patients with recurrent or metastatic gastric cancer
    Lan, Yan-qin
    Wu, Ri-ping
    Huang, Xiao-bing
    Wang, Xin-li
    Zhong, Dong-ta
    Huang, Chuan-yong
    Song, Jin-tian
    TUMORI JOURNAL, 2018, 104 (01): : 22 - 29
  • [25] Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) as secondline therapy for patients with advanced urothelial cancer
    Zhang, Sheng
    Xue, Hongxi
    Chen, Qiang
    ONCOTARGET, 2016, 7 (36) : 58579 - 58585
  • [26] Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer
    Jeong, J.
    Jeung, H. -C.
    Rha, S. Y.
    Im, C. K.
    Shin, S. J.
    Ahn, J. B.
    Noh, S. H.
    Roh, J. K.
    Chung, H. C.
    ANNALS OF ONCOLOGY, 2008, 19 (06) : 1135 - 1140
  • [27] Combination chemotherapy with 5-fluorouracil and heptaplatin as first-line treatment in patients with advanced gastric cancer
    Min, YJ
    Bang, SJ
    Shin, JW
    Kim, DH
    Park, JH
    Kim, GY
    Ko, BK
    Choi, DH
    Cho, HR
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2004, 19 (03) : 369 - 373
  • [28] A combination chemotherapy of 5-fluorouracil and cisplatin against advanced gastric cancer
    Imada, T
    Sairenji, M
    Suda, T
    Yamamoto, Y
    Amano, T
    Motohashi, H
    HEPATO-GASTROENTEROLOGY, 1999, 46 (25) : 594 - 600
  • [29] A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer
    Oh, Sung Yong
    Kwon, Hyuk-Chan
    Seo, Bong-Gun
    Kim, Sung-Hyun
    Kim, Jae-Seok
    Kim, Hyo-Jin
    ACTA ONCOLOGICA, 2007, 46 (03) : 336 - 341
  • [30] A predictive signature for oxaliplatin and 5-fluorouracil based chemotherapy in locally advanced gastric cancer
    Wang, Qinchuan
    Liu, Xiyong
    Chen, Chen
    Chen, Jida
    Xu, Beisi
    Chen, Lini
    Zhou, Jichun
    Huang, Yasheng
    Chen, Wenjun
    Teng, Rongyue
    Zhao, Wenhe
    Jin, Lidan
    Shen, Jun
    Shen, Jianguo
    Yen, Yun
    Wang, Linbo
    TRANSLATIONAL ONCOLOGY, 2021, 14 (01):
12345